Welcome to the ESTS 2025 Abstract Submission System

Late Breaking Clinical Trial Submission Deadline: Tuesday, 25 March 2025 - 23:59 (CET)

• Late Breaking Clinical Trial abstracts are targeted towards randomized clinical trial data, large population-based trial evidence, or novel translational evidence that is likely to be highly cited and impactful in clinical practice.
• Retrospective investigations or metanalyses will not be considered. Similarly, ad interim results of ongoing randomised trials will not be selected.
• Exempt from publication in EJCTS.
• Previously presented data can be submitted for consideration but this will be reviewed by the Program Committee and assessed for suitability to present.